secwatch.observer — SEC 8-K summary
======================================

Issuer:     CORCEPT THERAPEUTICS INC (CORT)
CIK:        0001088856
Form:       8-K
Filed at:   2023-12-11T23:59:59+00:00
Accession:  0001193125-23-292621
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corcept amends bylaws to strengthen director nomination and meeting rules
-------------------------------------------------------------------------

- Board can postpone, reschedule or cancel annual meetings even after notice has been sent to stockholders.
- Enhanced requirements for stockholder nominations and proposals; must comply with Rule 14a-19 and attend the meeting.
- Proxy card color rule: white cards reserved for Board; any other solicitation must use a different color.
- Eliminated requirement to make stockholder list available at meetings, aligning with recent Delaware law changes.
- Amendments effective December 5, 2023; govern meeting procedures and proxy solicitation mechanics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1088856/000119312523292621/0001193125-23-292621-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1088856/000119312523292621/d833600d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-292621

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer